Daniel B. is the Director of Bioinformatics at AstraZeneca, where he has progressed through roles of increasing seniority. He specializes in applying bioinformatics to drug discovery and development. He holds a Bachelors degree from Anglia Ruskin University and previously worked at Cambridge Epigenetix.
He is actively involved in recruitment for the Joint AstraZeneca-Cancer Research Horizon Functional Genomics Centre (FGC), highlighting his role in a key research collaboration.
Daniel B.
Director, Bioinformatics at AstraZeneca
United Kingdom
Overview
Topics They Care About
Functional Genomics
He is directly involved with the Joint AstraZeneca-Cancer Research Horizon Functional Genomics Centre, a major focus of his recent professional activity.
Bioinformatics Leadership
His career path shows a clear progression from scientist roles to a Director position at a major pharmaceutical company, indicating a focus on team and strategy leadership.
Oncology Research
[Predicted] His work within a functional genomics center that is a joint venture with a cancer research organization strongly suggests a focus on oncology.
Media Appearances
Daniel has no verified media appearances
Work History
7-2024
Director, Bioinformatics at AstraZeneca
2-2022
Associate Director at AstraZeneca
5-2020 - 3-2022
Senior Bioinformatics Scientist at AstraZeneca
2-2018 - 5-2020
Bioinformatics Scientist at Cambridge Epigenetix
3-2015 - 1-2018
Bioinformatics Consultant - Platform Specialist at Eagle Genomics Ltd.
2-2014 - 3-2015
Ensembl Genebuild Developer at EMBL EBI
8-2010 - 1-2014
ENCODE Developer at Wellcome Trust Sanger Institute
8-2001 - 8-2010
Senior Software Engineer at EMBL-EBI
Education
1998 - 2001
Bachelor's degree from Anglia Ruskin University
1985 - 1990
Education details unavailable from The Perse School, Hills Road, Cambridge
More Information
Social Presence :
Prographics :
Exp : 24
Location : United Kingdom
Job Level : Mid-senior
Designation : Director, Bioinformatics at AstraZeneca
